Corpus Intelligence IC Memo — GEORGETOWN MEMORIAL HOSPITAL 2026-04-26 04:04 UTC
IC Memo — GEORGETOWN MEMORIAL HOSPITAL
Investment Committee Memorandum | SC | 68 beds | Grade B | EBITDA uplift $12.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GEORGETOWN MEMORIAL HOSPITAL

CCN 420020 | GEORGETOWN, SC | 68 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

GEORGETOWN MEMORIAL HOSPITAL is a 68-bed suburban community hospital in GEORGETOWN, SC with $168.0M in net patient revenue and a -4.6% operating margin. The hospital serves a payer mix of 31.4% Medicare, 4.0% Medicaid, and 64.7% commercial.

Thesis: Turnaround. Our ML models identify $12.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.6% to 2.7% (+736bps).

Net Revenue HCRIS$168.0M
Current EBITDA COMPUTED$-7.8M
Operating Margin COMPUTED-4.6%
Occupancy HCRIS74.6%
Revenue / Bed COMPUTED$2.5M
Net-to-Gross HCRIS27.2%
Distress Probability ML40.4%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
47
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of -4.6% places it below the state median. Among 47 size-comparable peers (34-136 beds), the median margin is 6.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (34-136), prioritizing same-state peers. 47 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GEORGETOWN MEMORIAL HOSPITAL (Target)SC68$168.0M-4.6%
PH PATEWOOD HOSPITALSC64$229.8M38.0%
EAST COOPER REGIONAL MEDICAL CSC120$206.1M28.3%
OCONEE MEMORIAL HOSPITALSC131$190.4M5.2%
WACCAMAW COMMUNITY HOSPITALSC124$182.8M2.7%
HILTON HEAD HOSPITALSC109$165.7M29.2%
PH GREER MEMORIAL HOSPITALSC66$161.3M31.3%
PH BAPTIST PARKRIDGE HOSPITALSC78$159.8M18.1%
PELHAM MEDICAL CENTERSC48$137.2M17.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.5M+210bp18mo
Cost to Collect4.5%2.5%$3.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.0M+122bp9mo
Clean Claim Rate88.0%96.0%$108K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.5M
Cost to Collect
$3.4M
Denial Rate Reduction
$3.3M
A/R Days Reduction
$2.0M
Clean Claim Rate
$108K
Total EBITDA Uplift$12.4M
Current EBITDA$-7.8M
+ RCM Uplift+$12.4M
Pro Forma EBITDA$4.6M
Current Margin-4.6%
Pro Forma Margin2.7%
WC Released (1x)$6.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.0M$72.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.0M$75.5M0.00x-100.0%
Bull Case9.0x11.0x$-10.8M$112.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-10.8M$119.5M0.00x-100.0%
Bear Case11.0x10.0x$-13.2M$14.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.2M$11.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 47 hospitals with 34-136 beds
  • Same-state prioritization (n=48)
  • Comp margins: P25=-6.7% / P50=6.0% / P75=17.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.